These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 19949401

  • 1. Lessons from 60 years of pharmaceutical innovation.
    Munos B.
    Nat Rev Drug Discov; 2009 Dec; 8(12):959-68. PubMed ID: 19949401
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 2016 in review: FDA approvals of new molecular entities.
    Griesenauer RH, Kinch MS.
    Drug Discov Today; 2017 Nov; 22(11):1593-1597. PubMed ID: 28687460
    [Abstract] [Full Text] [Related]

  • 4. The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
    de la Torre BG, Albericio F.
    Molecules; 2018 Feb 27; 23(3):. PubMed ID: 29495494
    [Abstract] [Full Text] [Related]

  • 5. Cancer research in the United States: A critical review of current status and proposal for alternative models.
    Kantarjian HM, Prat F, Steensma DP, Kurzrock R, Stewart DJ, Sekeres MA, Leveque J.
    Cancer; 2018 Jul 15; 124(14):2881-2889. PubMed ID: 29757456
    [No Abstract] [Full Text] [Related]

  • 6. The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
    de la Torre BG, Albericio F.
    Molecules; 2020 Feb 09; 25(3):. PubMed ID: 32050446
    [Abstract] [Full Text] [Related]

  • 7. A forensic analysis of drug targets from 2000 through 2012.
    Munos B.
    Clin Pharmacol Ther; 2013 Sep 09; 94(3):407-11. PubMed ID: 23756372
    [Abstract] [Full Text] [Related]

  • 8. Drug discovery in jeopardy.
    Cuatrecasas P.
    J Clin Invest; 2006 Nov 09; 116(11):2837-42. PubMed ID: 17080187
    [Abstract] [Full Text] [Related]

  • 9. Trends in antimicrobial drug development: implications for the future.
    Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE.
    Clin Infect Dis; 2004 May 01; 38(9):1279-86. PubMed ID: 15127341
    [Abstract] [Full Text] [Related]

  • 10. Biopharmaceutical statistics in a pharmaceutical regulated environment: past, present, and future.
    Segreti AC, Leung HM, Koch GG, Davis RL, Mohberg NR, Peace KE.
    J Biopharm Stat; 2001 Nov 01; 11(4):347-72. PubMed ID: 12018784
    [Abstract] [Full Text] [Related]

  • 11. Data Integrity: History, Issues, and Remediation of Issues.
    Rattan AK.
    PDA J Pharm Sci Technol; 2018 Nov 01; 72(2):105-116. PubMed ID: 29158286
    [Abstract] [Full Text] [Related]

  • 12. 2020 in review: FDA approvals of new medicines.
    Kinch MS, Kraft Z, Schwartz T.
    Drug Discov Today; 2021 Dec 01; 26(12):2794-2799. PubMed ID: 34252611
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The impact of external innovation on new drug approvals: A retrospective analysis.
    Liu X, Thomas CE, Felder CC.
    Int J Pharm; 2019 May 30; 563():273-281. PubMed ID: 30664998
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rofecoxib, Merck, and the FDA.
    Kim PS, Reicin AS.
    N Engl J Med; 2004 Dec 30; 351(27):2875-8; author reply 2875-8. PubMed ID: 15625342
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT, Hagie F, Keen CL, Gershwin ME.
    Clin Ther; 2007 Jan 30; 29(1):1-16. PubMed ID: 17379043
    [Abstract] [Full Text] [Related]

  • 19. Bioequivalence: the regulatory career of a pharmaceutical concept.
    Carpenter D, Tobbell DA.
    Bull Hist Med; 2011 Jan 30; 85(1):93-131. PubMed ID: 21551918
    [Abstract] [Full Text] [Related]

  • 20. Pipelines turn to biotech.
    Lawrence S.
    Nat Biotechnol; 2007 Dec 30; 25(12):1342. PubMed ID: 18066015
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.